Page URL:

Key US stem cell lines returned to use

4 May 2010
Appeared in BioNews 556
US-based scientists working on embryonic stem cell (ES cell) research are relieved that the most important cell lines in their field have been approved for research by new government guidelines.

During the Bush administration, US government funding for research involving ES cells was restricted to just 20 cell lines, all of which were in existence before 9 August 2001. The Directive to this effect, passed by George W Bush in 2001, was repealed by the Obama administration in March 2009.

Executive Order 13505 ('Removing Barriers to Responsible Scientific Research Involving Human Stem Cells'), was supposed to facilitate future work but it also introduced much more strict guidelines regarding obtaining consent for donation of cells from embryos. Numerous cell lines had been obtained using various different consent procedures, so a panel was set up to verify which lines could be said to fall within the new guidelines. In the meantime, federal funding for research involving those cell lines was halted.

Serious concerns were raised about disruption to research involving five cell lines from the nonprofit WiCell organisation at the University of Winsconsin in particular. All five were previously approved but fell foul of the new regulations.

The H1 cell line, derived from an embryo donated by patients of a Winsconsin IVF clinic, was approved in January 2010. The H7, H9, H13 and H14 lines were only approved under the new rules at the end of April 2010. The delay was due to them being generated in institutes in Israel; finding the consent forms and translating from Hebrew to English took considerable time. The H9 cell line alone made up almost 40 per cent of orders from the now defunct National Stem Cell Bank, and was used for studies in over 500 journal publications.

The US National Institutes of Health (NIH) also recently approved nine other cell lines, bringing the total number in the NIH Stem Cell Registry to 64, according to the Washington Post. There are still 100 other cell lines waiting to be approved.

There was some criticism aimed at the delays introduced by the new bureaucracy, but NIH Director, Francis S Collins, said that the 'action should provide welcome reassurance to the many researchers who have been working on lines developed in the early days of stem cell research. Scientists can continue their studies without interruption, and we can all be assured that valuable work will not be lost.'

Biologists celebrate return of popular stem cell line
New Scientist |  28 April 2010
Key Bush-era stem cell lines win NIH go-ahead
Nature blogs |  28 April 2010
NIH Adds 13 Embryonic Stem Cell Lines to Approved List
MedPage Today |  28 April 2010
NIH Re-Approves Four Wisconsin Stem Cell Lines Including WiCell's H9
GenomeWeb |  28 April 2010
Popular stem cell line released from limbo
Science |  28 April 2010
Statement of NIH Director on Federal Funding for Embryonic Stem Cell Lines
NIH press release |  28 April 2010
23 May 2011 - by Nisha Satkunarajah 
The US Court of Appeals for the District of Columbia Circuit has overturned a preliminary injunction banning federal spending on research involving human embryonic stem cells (hESC)...
11 April 2011 - by Nishat Hyder 
The American states of Minnesota and Oklahoma are both in the process of passing legislation that will criminalise certain embryonic stem (ES) cell research procedures....
14 February 2011 - by Leo Perfect 
The University of California, San Francisco (UCSF), has opened a stem cell research facility paid for by private and state money approved by Californian voters. As no federal funds were used, researchers can avoid federal funding policy restrictions on human embryonic stem cell (hESC) research....
17 January 2011 - by Julianna Photopoulos 
An international team of researchers have found that both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) show higher genetic abnormalities than other cells....
13 December 2010 - by Dr Nadeem Shaikh 
The US courts are currently attempting to decide whether human embryonic stem cell (hESC) research may continue to receive federal funding, after a lawsuit was brought against the US Government last year....
19 April 2010 - by Nishat Hyder 
Over a year since US President Barack Obama announced his decision to allow federal funding for embryonic stem cell research, the widely utilised cell lines, H9 and H7, are still weeks away from receiving federal funding approval. The H9 and H7 cell lines were derived and approved under the Bush administration and are currently owned by WiCell Research Institute in Madison, Wisconsin. However, for months now the fate of these two much used lines has been uncertain. According to...
1 March 2010 - by Dr Jay Stone 
The US National Institutes of Health (NIH) has proposed a broader definition of 'human embryonic stem cell' (HES), which would allow Federal funding of research using cells at an early development stage....
1 February 2010 - by Nishat Hyder 
The US National Institutes of Health (NIH) has approved the first human embryonic stem cell (ES) line from the George W Bush era, according to Nature News. It will be included on the National Stem Cell Registry (NSCR), ensuring its eligibility for federal funding....
21 December 2009 - by Nishat Hyder 
The scientific research community in the US has had much cause to celebrate this past year following President Obama taking office and swiftly implementing a decidedly more liberal policy towards human embryonic stem cell (ES) research than was hitherto in place. Earlier this month the National Institutes of Health (NIH) approved 13 new ES cell lines under the new ethical standards. However, the granting of federal funding for research projects on ES cell lines - a key policy c...
11 December 2009 - by Nishat Hyder 
Regulators in the US have approved 13 new human embryonic stem cell (ES cell)lines - the first to be approved since President Obama lifted the restriction on stem cell research earlier this year in March. The 13 stem cell lines are the first the National Institutes of Health (NIH) has approved under the ethical guidelines that were unveiled in July; they are also the first new stem cells lines available to US scientists in almost a decade. It is hoped that the new lines, which are of
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.